Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling-Reference-Cited by-同舟云学术

Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling

Author:

Kremer Ingrid E. H.¹^ORCID,Evers Silvia M. A. A.¹²,Jongen Peter J.³⁴,Hiligsmann Mickaël¹

Affiliation:

1. Department of Health Services Research; Care and Public Health Research Institute (CAPHRI); Maastricht University; Maastricht The Netherlands

2. Center for Economic Evaluations; Trimbos Institute Netherlands Institute of Mental Health and Addiction; Utrecht The Netherlands

3. MS4 Research Institute; Nijmegen The Netherlands

4. Department of Community & Occupational Medicine; University Medical Centre Groningen; Groningen The Netherlands

Funder

Bayer B.V.

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health

Link

Reference30 articles.

4. U. S. Food and Drug Administration Drugs@FDA: FDA approved drug products http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm

5. European Medicines Agency European public assessment reports http://www.ema.europa.eu/ema/

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献